Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1863, Issue 8, 2017, Pages 2012-2018

  Jia, Guanghong ^a,b   Jia, Yan ^a   Sowers, James R ^a,b  

^a University of Missouri   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diastolic heart failure; Females; Insulin resistance; Mineralocorticoid receptors; Obesity

Indexed keywords

MINERALOCORTICOID RECEPTOR; MUSCLE PROTEIN;

CELL SPECIFICITY; DIASTOLIC DYSFUNCTION; EPIGENETICS; GENE ACTIVATION; HEART PROTECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; MICROVASCULARIZATION; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; ANIMAL; DIABETIC CARDIOMYOPATHY; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; EPIGENESIS, GENETIC; HUMANS; MUSCLE PROTEINS; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTORS, MINERALOCORTICOID; SIGNAL TRANSDUCTION;

EID: 85006324089     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2016.10.025     Document Type: Review

References (69)

1. Jindal, A., Whaley-Connell, A., Sowers, J.R., Obesity and heart failure as a mediator of the cerebrorenal interaction. Contrib. Nephrol. 179 (2013), 15–23.
2. Kenchaiah, S., Evans, J.C., Levy, D., Wilson, P.W., Benjamin, E.J., Larson, M.G., Kannel, W.B., Vasan, R.S., Obesity and the risk of heart failure. N. Engl. J. Med. 347 (2002), 305–313.
3. Maisch, B., Alter, P., Pankuweit, S., Diabetic cardiomyopathy–fact or fiction?. Herz 36 (2011), 102–115.
4. Wong, A.K., AlZadjali, M.A., Choy, A.M., Lang, C.C., Insulin resistance: a potential new target for therapy in patients with heart failure. Cardiovasc. Ther. 26 (2008), 203–213.
5. Witteles, R.M., Fowler, M.B., Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J. Am. Coll. Cardiol. 51 (2008), 93–102.
6. Falcao-Pires, I., Leite-Moreira, A.F., Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail. Rev. 17 (2012), 325–344.
7. Ivanes, F., Susen, S., Mouquet, F., Pigny, P., Cuilleret, F., Sautiere, K., Collet, J.P., Beygui, F., Hennache, B., Ennezat, P.V., Juthier, F., Richard, F., Dallongeville, J., Hillaert, M.A., Doevendans, P.A., Jude, B., Bertrand, M., Montalescot, G., Van Belle, E., Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure. Eur. Heart J. 33 (2012), 191–202.
8. Shen, J.Z., Young, M.J., Corticosteroids, heart failure, and hypertension: a role for immune cells?. Endocrinology 153 (2012), 5692–5700.
9. Pandey, A., Garg, S., Matulevicius, S.A., Shah, A.M., Garg, J., Drazner, M.H., Amin, A., Berry, J.D., Marwick, T.H., Marso, S.P., de Lemos, J.A., Kumbhani, D.J., Effect of mineralocorticoid receptor antagonists on cardiac structure and function in patients with diastolic dysfunction and heart failure with preserved ejection fraction: a meta-analysis and systematic review. J. Am. Heart Assoc., 4, 2015, e002137.
10. Jia, G., Sowers, J.R., Endothelial dysfunction potentially interacts with impaired glucose metabolism to increase cardiovascular risk. Hypertension 64 (2014), 1192–1193.
11. Jia, G., DeMarco, V.G., Sowers, J.R., Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat. Rev. Endocrinol. 12 (2016), 144–153.
12. Sverdlov, A.L., Elezaby, A., Qin, F., Behring, J.B., Luptak, I., Calamaras, T.D., Siwik, D.A., Miller, E.J., Liesa, M., Shirihai, O.S., Pimentel, D.R., Cohen, R.A., Bachschmid, M.M., Colucci, W.S., Mitochondrial reactive oxygen species mediate cardiac structural, functional, and mitochondrial consequences of diet-induced metabolic heart disease. J. Am. Heart Assoc., 5, 2016, 10.1161/JAHA.115.002555.
13. Wang, Y.C., Liang, C.S., Gopal, D.M., Ayalon, N., Donohue, C., Santhanakrishnan, R., Sandhu, H., Perez, A.J., Downing, J., Gokce, N., Colucci, W.S., Ho, J.E., Preclinical systolic and diastolic dysfunctions in metabolically healthy and unhealthy obese individuals. Circ. Heart Fail. 8 (2015), 897–904.
14. Hsu, P.C., Tsai, W.C., Lin, T.H., Su, H.M., Voon, W.C., Lai, W.T., Sheu, S.H., Association of arterial stiffness and electrocardiography-determined left ventricular hypertrophy with left ventricular diastolic dysfunction. PLoS One, 7, 2012, e49100.
15. Borlaug, B.A., Paulus, W.J., Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur. Heart J. 32 (2011), 670–679.
16. Teo, L.Y., Chan, L.L., Lam, C.S., Heart failure with preserved ejection fraction in hypertension. Curr. Opin. Cardiol. 31 (2016), 410–416.
17. LeWinter, M.M., Zile, M.R., Could modification of titin contribute to an answer for HFpEF?. Circulation, 2016 (pii: CIRCULATIONAHA.116.023648).
18. Methawasin, M., Strom, J.G., Slater, R.E., Fernandez, V., Saripalli, C., Granzier, H.L., Experimentally increasing titin's compliance through RBM20 inhibition improves diastolic function in a mouse model of HFpEF. Circulation, 2016 (pii: CIRCULATIONAHA.116.023003).
19. Nagueh, S.F., Shah, G., Wu, Y., Torre-Amione, G., King, N.M., Lahmers, S., Witt, C.C., Becker, K., Labeit, S., Granzier, H.L., Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110 (2004), 155–162.
20. Sowers, J.R., Hypertension, angiotensin II, and oxidative stress. N. Engl. J. Med. 346 (2002), 1999–2001.
21. Jia, G., Habibi, J., Aroor, A.R., Martinez-Lemus, L.A., DeMarco, V.G., Ramirez-Perez, F.I., Sun, Z., Hayden, M.R., Meininger, G.A., Mueller, K.B., Jaffe, I.Z., Sowers, J.R., Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females. Circ. Res. 118 (2016), 935–943.
22. Jia, G., Habibi, J., DeMarco, V.G., Martinez-Lemus, L.A., Ma, L., Whaley-Connell, A.T., Aroor, A.R., Domeier, T.L., Zhu, Y., Meininger, G.A., Barrett Mueller, K., Jaffe, I.Z., Sowers, J.R., Endothelial mineralocorticoid receptor deletion prevents diet-induced cardiac diastolic dysfunction in females. Hypertension 66 (2015), 1159–1167.
23. Bostick, B., Habibi, J., DeMarco, V.G., Jia, G., Domeier, T.L., Lambert, M.D., Aroor, A.R., Nistala, R., Bender, S.B., Garro, M., Hayden, M.R., Ma, L., Manrique Acevedo, C., Sowers, J.R., Mineralocorticoid receptor blockade prevents western diet-induced diastolic dysfunction in female mice. Am. J. Physiol. Heart Circ. Physiol. 308 (2015), H1126–H1135.
24. Habibi, J., DeMarco, V.G., Ma, L., Pulakat, L., Rainey, W.E., Whaley-Connell, A.T., Sowers, J.R., Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression. Am. J. Physiol. Heart Circ. Physiol. 300 (2011), H1484–H1491.
25. Bender, S.B., DeMarco, V.G., Padilla, J., Jenkins, N.T., Habibi, J., Garro, M., Pulakat, L., Aroor, A.R., Jaffe, I.Z., Sowers, J.R., Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction. Hypertension, 2015, 1082–1088.
26. Cannon, J.A., Collier, T.J., Shen, L., Swedberg, K., Krum, H., Van Veldhuisen, D.J., Vincent, J., Pocock, S.J., Pitt, B., Zannad, F., McMurray, J.J., Clinical outcomes according to QRS duration and morphology in the eplerenone in mild patients: hospitalization and survival study in heart failure (EMPHASIS-HF). Eur. J. Heart Fail. 17 (2015), 707–716.
27. Filippatos, G., Anker, S.D., Bohm, M., Gheorghiade, M., Kober, L., Krum, H., Maggioni, A.P., Ponikowski, P., Voors, A.A., Zannad, F., Kim, S.Y., Nowack, C., Palombo, G., Kolkhof, P., Kimmeskamp-Kirschbaum, N., Pieper, A., Pitt, B., A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease. Eur. Heart J. 37 (2016), 2105–2114.
28. Sciarretta, S., Paneni, F., Palano, F., Chin, D., Tocci, G., Rubattu, S., Volpe, M., Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin. Sci. (Lond.) 116 (2009), 467–477.
29. Shah, A.M., Shah, S.J., Anand, I.S., Sweitzer, N.K., O'Meara, E., Heitner, J.F., Sopko, G., Li, G., Assmann, S.F., McKinlay, S.M., Pitt, B., Pfeffer, M.A., Solomon, S.D., Investigators, T., Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ. Heart Fail. 7 (2014), 104–115.
30. Pitt, B., Pfeffer, M.A., Assmann, S.F., Boineau, R., Anand, I.S., Claggett, B., Clausell, N., Desai, A.S., Diaz, R., Fleg, J.L., Gordeev, I., Harty, B., Heitner, J.F., Kenwood, C.T., Lewis, E.F., O'Meara, E., Probstfield, J.L., Shaburishvili, T., Shah, S.J., Solomon, S.D., Sweitzer, N.K., Yang, S., McKinlay, S.M., Investigators, T., Spironolactone for heart failure with preserved ejection fraction. N. Engl. J. Med. 370 (2014), 1383–1392.
31. Stas, S., Whaley-Connell, A., Habibi, J., Appesh, L., Hayden, M.R., Karuparthi, P.R., Qazi, M., Morris, E.M., Cooper, S.A., Link, C.D., Stump, C., Hay, M., Ferrario, C., Sowers, J.R., Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of NADPH oxidase and cardiac remodeling. Endocrinology 148 (2007), 3773–3780.
32. Bender, S.B., DeMarco, V.G., Padilla, J., Jenkins, N.T., Habibi, J., Garro, M., Pulakat, L., Aroor, A.R., Jaffe, I.Z., Sowers, J.R., Mineralocorticoid receptor antagonism treats obesity-associated cardiac diastolic dysfunction. Hypertension 65 (2015), 1082–1088.
33. DeMarco, V.G., Habibi, J., Jia, G., Aroor, A.R., Ramirez-Perez, F.I., Martinez-Lemus, L.A., Bender, S.B., Garro, M., Hayden, M.R., Sun, Z., Meininger, G.A., Manrique, C., Whaley-Connell, A., Sowers, J.R., Low-Dose mineralocorticoid receptor blockade prevents western diet-induced arterial stiffening in female mice. Hypertension 66 (2015), 99–107.
34. Bene, N.C., Alcaide, P., Wortis, H.H., Jaffe, I.Z., Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease. Steroids 91 (2014), 38–45.
35. Rickard, A.J., Morgan, J., Chrissobolis, S., Miller, A.A., Sobey, C.G., Young, M.J., Endothelial cell mineralocorticoid receptors regulate deoxycorticosterone/salt-mediated cardiac remodeling and vascular reactivity but not blood pressure. Hypertension 63 (2014), 1033–1040.
36. Rickard, A.J., Morgan, J., Bienvenu, L.A., Fletcher, E.K., Cranston, G.A., Shen, J.Z., Reichelt, M.E., Delbridge, L.M., Young, M.J., Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis. Hypertension 60 (2012), 1443–1450.
37. Usher, M.G., Duan, S.Z., Ivaschenko, C.Y., Frieler, R.A., Berger, S., Schutz, G., Lumeng, C.N., Mortensen, R.M., Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J. Clin. Invest. 120 (2010), 3350–3364.
38. Li, C., Zhang, Y.Y., Frieler, R.A., Zheng, X.J., Zhang, W.C., Sun, X.N., Yang, Q.Z., Ma, S.M., Huang, B., Berger, S., Wang, W., Wu, Y., Yu, Y., Duan, S.Z., Mortensen, R.M., Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice. PLoS One, 9, 2014, e110950.
39. Gueret, A., Harouki, N., Favre, J., Galmiche, G., Nicol, L., Henry, J.P., Besnier, M., Thuillez, C., Richard, V., Kolkhof, P., Mulder, P., Jaisser, F., Ouvrard-Pascaud, A., Vascular smooth muscle mineralocorticoid receptor contributes to coronary and left ventricular dysfunction after myocardial infarction. Hypertension 67 (2016), 717–723.
40. Bienvenu, L.A., Reichelt, M.E., Morgan, J., Fletcher, E.K., Bell, J.R., Rickard, A.J., Delbridge, L.M., Young, M.J., Cardiomyocyte mineralocorticoid receptor activation impairs acute cardiac functional recovery after ischemic insult. Hypertension 66 (2015), 970–977.
41. Tirosh, A., Garg, R., Adler, G.K., Mineralocorticoid receptor antagonists and the metabolic syndrome. Curr. Hypertens. Rep. 12 (2010), 252–257.
42. McCurley, A., Pires, P.W., Bender, S.B., Aronovitz, M., Zhao, M.J., Metzger, D., Chambon, P., Hill, M.A., Dorrance, A.M., Mendelsohn, M.E., Jaffe, I.Z., Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med. 18 (2012), 1429–1433.
43. Shen, J.Z., Morgan, J., Tesch, G.H., Rickard, A.J., Chrissobolis, S., Drummond, G.R., Fuller, P.J., Young, M.J., Cardiac tissue injury and remodeling is dependent upon MR regulation of activation pathways in cardiac tissue macrophages. Endocrinology 157 (2016), 3213–3223.
44. DeMarco, V.G., Aroor, A.R., Sowers, J.R., The pathophysiology of hypertension in patients with obesity. Nat. Rev. Endocrinol. 10 (2014), 364–376.
45. Nistala, R., Sowers, J.R., Hypertension: synergy of antihypertensives in elderly patients with CKD. Nat. Rev. Nephrol. 9 (2013), 13–15.
46. Jia, G., Aroor, A.R., Martinez-Lemus, L.A., Sowers, J.R., Overnutrition, mTOR signaling, and cardiovascular diseases. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307 (2014), R1198–R1206.
47. Jia, G., Habibi, J., Bostick, B.P., Ma, L., DeMarco, V.G., Aroor, A.R., Hayden, M.R., Whaley-Connell, A.T., Sowers, J.R., Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet. Hypertension 65 (2015), 531–539.
48. Kim, J.A., Jang, H.J., Martinez-Lemus, L.A., Sowers, J.R., Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation. Am. J. Physiol. Endocrinol. Metab. 302 (2012), E201–E208.
49. Mori, J., Alrob, O.A., Wagg, C.S., Harris, R.A., Lopaschuk, G.D., Oudit, G.Y., ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am. J. Physiol. Heart Circ. Physiol. 304 (2013), H1103–H1113.
50. Asrih, M., Mach, F., Nencioni, A., Dallegri, F., Quercioli, A., Montecucco, F., Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome. Mediat. Inflamm., 2013, 2013, 367245.
51. Weirather, J., Hofmann, U.D., Beyersdorf, N., Ramos, G.C., Vogel, B., Frey, A., Ertl, G., Kerkau, T., Frantz, S., Foxp3 + CD4 + T cells improve healing after myocardial infarction by modulating monocyte/macrophage differentiation. Circ. Res. 115 (2014), 55–67.
52. Ikonomidis, I., Lambadiari, V., Pavlidis, G., Koukoulis, C., Kousathana, F., Varoudi, M., Spanoudi, F., Maratou, E., Parissis, J., Triantafyllidi, H., Paraskevaidis, I., Dimitriadis, G., Lekakis, J., Insulin resistance and acute glucose changes determine arterial elastic properties and coronary flow reserve in dysglycaemic and first-degree relatives of diabetic patients. Atherosclerosis 241 (2015), 455–462.
53. Hayden, M.R., Habibi, J., Joginpally, T., Karuparthi, P.R., Sowers, J.R., Ultrastructure study of transgenic Ren2 Rat Aorta — part 1: endothelium and intima. Cardiorenal Med. 2 (2012), 66–82.
54. Castorena-Gonzalez, J.A., Staiculescu, M.C., Foote, C.A., Polo-Parada, L., Martinez-Lemus, L.A., The obligatory role of the actin cytoskeleton on inward remodeling induced by dithiothreitol activation of endogenous transglutaminase in isolated arterioles. Am. J. Physiol. Heart Circ. Physiol. 306 (2014), H485–H495.
55. Castorena-Gonzalez, J.A., Staiculescu, M.C., Foote, C., Martinez-Lemus, L.A., Mechanisms of the inward remodeling process in resistance vessels: is the actin cytoskeleton involved?. Microcirculation 21 (2014), 219–229.
56. van Leeuwen, N., Kumsta, R., Entringer, S., de Kloet, E.R., Zitman, F.G., DeRijk, R.H., Wust, S., Functional mineralocorticoid receptor (MR) gene variation influences the cortisol awakening response after dexamethasone. Psychoneuroendocrinology 35 (2010), 339–349.
57. Luo, J.Q., Wang, L.Y., He, F.Z., Sun, N.L., Tang, G.F., Wen, J.G., Luo, Z.Y., Liu, Z.Q., Zhou, H.H., Chen, X.P., Zhang, W., Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment. Pharmacogenomics 15 (2014), 201–208.
58. Jaisser, F., Farman, N., Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology. Pharmacol. Rev. 68 (2016), 49–75.
59. Cavallari, L.H., Groo, V.L., Viana, M.A., Dai, Y., Patel, S.R., Stamos, T.D., Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure. Pharmacotherapy 30 (2010), 1–9.
60. Alikhani-Koopaei, R., Fouladkou, F., Frey, F.J., Frey, B.M., Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J. Clin. Invest. 114 (2004), 1146–1157.
61. Sober, S., Laan, M., Annilo, T., MicroRNAs miR-124 and miR-135a are potential regulators of the mineralocorticoid receptor gene (NR3C2) expression. Biochem. Biophys. Res. Commun. 391 (2010), 727–732.
62. Gekle, M., Bretschneider, M., Meinel, S., Ruhs, S., Grossmann, C., Rapid mineralocorticoid receptor trafficking. Steroids 81 (2014), 103–108.
63. Duprez, D., Jacobs, D.R. Jr., Arterial stiffness and left ventricular diastolic function: does sex matter?. Hypertension 60 (2012), 283–284.
64. Regitz-Zagrosek, V., Brokat, S., Tschope, C., Role of gender in heart failure with normal left ventricular ejection fraction. Prog. Cardiovasc. Dis. 49 (2007), 241–251.
65. Mosca, L., Manson, J.E., Sutherland, S.E., Langer, R.D., Manolio, T., Barrett-Connor, E., Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing group. Circulation 96 (1997), 2468–2482.
66. Rutter, M.K., Parise, H., Benjamin, E.J., Levy, D., Larson, M.G., Meigs, J.B., Nesto, R.W., Wilson, P.W., Vasan, R.S., Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham heart study. Circulation 107 (2003), 448–454.
67. Manrique, C., DeMarco, V.G., Aroor, A.R., Mugerfeld, I., Garro, M., Habibi, J., Hayden, M.R., Sowers, J.R., Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a western diet. Endocrinology 154 (2013), 3632–3642.
68. Mihailidou, A.S., Ashton, A.W., Cardiac effects of aldosterone: does gender matter?. Steroids 91 (2014), 32–37.
69. Vasan, R.S., Evans, J.C., Benjamin, E.J., Levy, D., Larson, M.G., Sundstrom, J., Murabito, J.M., Sam, F., Colucci, W.S., Wilson, P.W., Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham heart study. Hypertension 43 (2004), 957–962.